Search
Levocetirizine
go.drugbank.com/drugs/DB06282ApprovedInvestigational[L7694] Levocetirizine has greater affinity for the histamine H<sub>1</sub> receptor than cetirizine.[L7694] Levocetirizine was granted FDA approval in 1995.[L7694] … Levocetirizine is a selective histamine H<sub>1</sub> antagonist used to treat a variety of allergic symptoms.[A181748,A181790,L7694] It is the R enantiomer of [cetirizine].
Synonyms: Levocetirizine, LevocetirizinaSalts: Levocetirizine dihydrochlorideLevocetirizine H1-Antihistamine Action
smpdb.ca/view/SMP0059114Drug actionLevocetirizine is a second-generation piperazine H1-antihistamine.
Levocetirizine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175093Drug actionLevocetirizine is an H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria.
Levocetirizine H1-Antihistamine Blood Vessel Constriction Action Pathway
smpdb.ca/view/SMP0175001Drug actionLevocetirizine inhibits the H1 histamine receptor on blood vessel endothelial cells. … Levocetirizine is an H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria.
Levocetirizine H1 Antihistamine Smooth Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0174909Drug actionLevocetirizine also inhibits the H1 histamine receptor on bronchiole smooth muscle myocytes. … Levocetirizine is an H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria.
Imiquimod
go.drugbank.com/drugs/DB00724ApprovedInvestigationalImiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear ...
Mixtures: Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Niacinamide 2%, Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05%Mupirocin
go.drugbank.com/drugs/DB00410ApprovedInvestigationalVet approvedMupirocin, formerly termed pseudomonic acid A, is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism Pseudomonas fluorescens, mu...
Mixtures: Levocetirizine Dihydrochloride 2% / Mupirocin 2% / Triamcinolone Acetonide 0.025%Clobetasol propionate
go.drugbank.com/drugs/DB01013ApprovedInvestigationalClobetasol propionate is a prednisolone derivative with higher specificity for glucocorticoid receptors than mineralocorticoid receptors. It has demonstrated superior activity compared to fluocinonide and was first described in the liter...
Mixtures: Clobetasol Propionate 0.05% / Levocetirizine Dihydrochloride 2%Tretinoin
go.drugbank.com/drugs/DB00755ApprovedInvestigationalNutraceuticalTretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). It is an oxidation product in the physiological pathway of vitamin A metabolism. In human circulation, tretinoin is norm...
Mixtures: Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05%, Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05%Montelukast
go.drugbank.com/drugs/DB00471ApprovedInvestigationalMontelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs. Although capable of demonstrating effectiv...
Mixtures: Glencet M (Montelukast 10mg/ Levocetirizine dihydrochloride 5mg) Film-Coated Tablet